|

CD70-targeted CAR-T cells Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Chongqing Precision Biotech Co., Ltd1

Indications

  • Anaplastic Thyroid Carcinomas1
  • Renal Cell Carcinoma (RCC)1
  • Thymic Carcinoma1
  • Ovarian Cancer1
  • Cervical Cancer1

Other1 trial

CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.